glp 1 receptor agonists weight loss How GLP-1 Evolved from Diabetes to Treatments GLP-1 receptor agonists | How

Despite extensive investment in MASH drug development, only one medication (resmetirom) has been officially approved for MASH treatment to date

[DOI] [PMC free article] [PubMed] 66.Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity in Major Markets, Disease Overview and Drug Forecast to 2033

Lancet 2006;368:1696705.ArticlePubMed 22

& Smith, T

Gariani and Putzu 2024)

To view digital features for this article go to Introduction Obesity (defined as a body mass index [BMI] 30 kg/m 2 in adults [1]) is a major health concern in the USA [2] and is associated with multiple complications, including cardiovascular disease, type 2 diabetes, and osteoarthritis [3,4,5,6,7,8]